Advaxis (ADXS) 10-Q2010 Q3 Quarterly report

Filed: 14 Sep 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: anytime, discretion, eligible, fewer, identical, insufficient, iv, newly, quoted, redemption, repurchase, slightly, vi

Removed: Aintree, announced, attributed, Authority, Cardiff, chemotherapy, commercial, consummated, contingently, converted, corporation, CRUK, decrease, dendritic, developed, divided, earning, efficacy, EITF, enter, entity, evaluating, failed, feature, finalized, fund, health, Hospital, indexed, Jersey, killer, liable, licensing, line, Liverpool, London, Marsden, maximum, mutually, national, natural, partially, patient, philanthropy, qualified, ratified, receipt, recruiting, reimburse, respond, Royal, safety, small, sophisticated, state, study, subscription, Transfer

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ADXS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION-PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT OF 2002

The undersigned as the Chief Financial Officer of Advaxis, Inc. (the “Company”), does hereby certify that the foregoing Quarterly Report on Form 10-Q of the Company for the quarter ended July 31, 2010:

(1)

Fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)

Fairly presents, in all material respects, the financial condition and result of operations of the Company.

September 14, 2010

/s/ Mark J. Rosenblum

Mark J. Rosenblum

Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.